Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Ransi Nayakarathna

ResearcherPublications, citations & collaboration network

Ransi Nayakarathna is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 3 works, 28 citations, an h-index of 2 and an i10-index of 1.

3
Works
28
Citations
2
h-index
1
i10-index

How has Ransi Nayakarathna's publication output changed over time?

ScholarIQpublication output · 2022–2023

Output declined50% over the shown period — from 2 works in 2022 to 1 in 2023.

2
1
20222023

What are the most-cited papers on Ransi Nayakarathna?

ScholarIQmost cited works
Early access for innovative oncology medicines: a different story in each nation
Tara Cowling, Ransi Nayakarathna, Allison Wills, Dipti Tankala, Nancy Paul Roc, Stéphane Barakat
Journal of Medical Economics. 202323 CitationsOPEN ACCESS
Virtual Care Use in Primary Care or Specialty Care Settings
Ransi Nayakarathna, Heather K. Neilson, Danielle MacDougall, Tara Cowling
Canadian Journal of Health Technologies. 20225 CitationsOPEN ACCESS
Low-Dose Ipilimumab in Combination With Nivolumab or Pembrolizumab for the Treatment of Advanced Melanoma
Tara Cowling, Heather K. Neilson, Ransi Nayakarathna, Quenby Mahood
Canadian Journal of Health Technologies. 20220 CitationsOPEN ACCESS

Related on ScholarIQ

Early access for innovative oncology medicines: a different story in each nation
Paper
Virtual Care Use in Primary Care or Specialty Care Settings
Paper
Low-Dose Ipilimumab in Combination With Nivolumab or Pembrolizumab for the Treatment of Advanced Melanoma
Paper
Cancer Immunotherapy and Biomarkers
Topic
Health Systems, Economic Evaluations, Quality of Life
Topic
Telemedicine and Telehealth Implementation
Topic
470M+ articles · free account